| Document |
Document Title |
|
WO/2006/001537A1 |
A process for producing a hydrazone compound represented by the general formula (5) which comprises the step of condensing a hydrazine compound represented by the general formula (3) with a carbonyl compound represented by the general fo...
|
|
WO/2006/000836A1 |
A process for the preparation of anastrozole.
|
|
WO/2005/123668A1 |
The present invention discloses novel compounds of Formula I, or pharmaceutically acceptable salts thereof, which have glucagon receptor antagonist or inverse agonist activity, as well as methods for preparing such compounds. In another ...
|
|
WO/2005/121074A2 |
The invention relates to processes for the preparation of Schiff's base, and to the use of Schiff's base as intermediate in the preparation of naphthalenamine derivatives which are active compounds for treating the anxiety related disord...
|
|
WO/2005/113487A2 |
The invention is directed to novel compounds that are used in the formation of polyurea compositions, including one-part and two-part polyurea compositions. The invention is also directed to polyureas formed from such compounds, cross-li...
|
|
WO/2005/110975A1 |
The invention relates to substituted cyclohexyl-1,4-diamine derivatives, to a method for their production, to medicaments containing said compounds and to the use of substituted cyclohexyl-1,4-diamine derivatives for producing medicaments.
|
|
WO/2005/105734A1 |
Novel unsymmetrical diimines containing a polar group are made by preparing a mixture of the unsymmetrical diimine and two symmetrical diimines, for example by reacting a dicarbonyl compound with two primary amines. The unsymmetrical dii...
|
|
WO/2005/105764A1 |
Compounds of the formula (I): in which R, R1 and R2 are as defined in the description, the use thereof for the treatment of dyslipidaemia, atherosclerosis and diabetes, pharmaceutical compositions comprising them, and . processes for the...
|
|
WO/2005/105896A1 |
The invention relates to a molecule comprising at least one carbon-carbon double bond which is substituted by at least one cyclopentadienyl-metal-cyclopentadienyl complex, having the cis/trans isomerisation property, in a reversible mann...
|
|
WO/2005/100303A1 |
The inventive indene derivatives of formula (I) are capable of selectively modulating the activities of peroxisome proliferator activated receptors (PPARs), causing no adverse side effects, and thus, they are useful for the treatment and...
|
|
WO/2005/094805A1 |
A medicine having prostaglandin D2 (PGD2) production inhibitory activity and having as an active ingredient a substance selected from compounds represented by the general formula (I): A-Y-B &lcub wherein A and B each independently repres...
|
|
WO/2005/095330A1 |
Formula (I), wherein X represents a group -O-A1- or a group -N=A2-, Y represents a single bond, O or S, or X and Y together may represent O, Q represents an aryl group that may be optionally substituted, a heterocyclic group that may be ...
|
|
WO/2005/093004A1 |
Disclosed are an agent and method for controlling gelation which are capable of completely controlling the fluidity of a fluid compound. Specifically disclosed is a gelation controlling agent which is added to a fluid compound for transf...
|
|
WO/2005/085183A1 |
The invention relates to a method of preparing benzazepine compounds having general formula (IA) consisting in reacting at least one compound having general formula (IIA) with an olefin, the compound thus obtained then being cyclised suc...
|
|
WO/2005/085216A1 |
An isoxazoline-substituted benzamide compound of the general formula: (1) [wherein each of A1, A2 and A3 independently represents a carbon atom or nitrogen atom; G a benzene ring, etc.; W an oxygen atom or sulfur atom; X a halogen atom, ...
|
|
WO/2005/085174A1 |
Disclosed is a method for producing an optically active 1-aryl-2-fluoro-substituted ethylamine represented by the following general formula [2]: [wherein Ar represents an aryl group; n represents an integer of 1 or 2; and * represents an...
|
|
WO/2005/085189A2 |
The present invention relates to compounds of formula (I), or pharmaceutically acceptable salts thereof, wherein X is selected from (II) and (III), Y is selected from SO2NH, CONH, CH=N, CH2NH and CH=CH; R1-5 are each independently select...
|
|
WO/2005/082882A1 |
The invention relates to compounds of general formula (I), where R1 and R2 are independently selected from a hydrogen atom, a branched or straight chain alkyl with 1 to 6 carbon atoms, a fluoroalkyl group with 1 to 6 carbon atoms and 3 t...
|
|
WO/2005/082956A1 |
Disclosed is a photosensitive resin composition used for interlayer insulating films or surface protection films which has excellent resolution and can be developed with an aqueous alkaline solution. The photosensitive resin composition ...
|
|
WO/2005/082841A1 |
The present invention relates to immunosuppressants, processes for their production, their uses and pharmaceutical compositions containing them. The invention provides a novel class of compounds useful in the treatment or prevention of d...
|
|
WO/2005/080327A1 |
Disclosed are compounds of Formula I, and their N-oxides and suitable salts thereof, which are useful for controlling invertebrate pests. I wherein Q is Q-1 or Q-2; Y is H, F, Cl or CH3; A is CN, C1-C6 alkyl, ORla, SRla, NRlaR2a or CONR1...
|
|
WO2005063665B1 |
The invention provides para substituted dialkylphenol derivatives of propofol. The invention further provides pharmaceutical compositions comprising such analogs, methods for preparing such analogs, and methods of using such analogs to i...
|
|
WO/2005/079863A1 |
It is intended to provide a contrast medium for thrombus formation capable of binding specifically to a thrombus, lowering background noise and thus improving the resolution in a contrast examination for thrombus formation; and a method ...
|
|
WO/2005/079774A2 |
A drug may be used in the preparation of a medicament for the treatment or prevention of an ophthalmologic disorder, wherein the drug inihibits, antagonizes, or shortÂcircuits the visual cycle at a step of the visual cycle that occurs o...
|
|
WO/2005/075501A1 |
A process for forming a conjugate of a polyoxyalkylene polymer (such as polyethylene glycol) with a compound containing an amine group(s) and/or a sulfide group(s) by reacting the compound with an acrylate terminated polyoxyalkylene (suc...
|
|
WO/2005/073196A1 |
A compound of the following formula (I). This compound (I) can be produced by reacting a 1,1'-binaphthyl 2,2'-dimethylenebromide derivative which can be produced through a relatively small number of steps with an easily available seconda...
|
|
WO/2005/068415A1 |
Disclosed is a phenylalanine derivative having excellent VLA-4 inhibitory activity which is represented by the following general formula (1) or a salt thereof. (1) (In the formula, R1 represents an aromatic hydrocarbon group having 6-10 ...
|
|
WO/2005/066116A1 |
Compounds of the formula where the variables are as defined in the specification, are useful for preventing or treating emphysema and related pulmonary conditions of mammals and other diseases and conditions which are responsive to RAR&g...
|
|
WO/2005/066115A2 |
Compounds of the formula where the variables have the values described in the specification are antagonists of RAR&gammad retinoid receptors.
|
|
WO/2005/063222A1 |
An Hsp90 family protein inhibitor which contains as an active ingredient a benzene derivative represented by the following general formula (I), a prodrug thereof, or a pharmacologically acceptable salt of either.
|
|
WO/2005/063018A1 |
Present invention relates to a haloalkene compound of the formula (I)or its salt: wherein each of X1 and X2 is halogen; Y is alkyl, haloalkyl or phenyl; n is 0 to 5; L is -C(=B)Q, -C(=B)B’Q, -C(=B)N(D)Q, -N(D)Q, -N(D)C(=B)Q, -N(D)C(=B)...
|
|
WO/2005/063840A1 |
The present invention pertains to non-fugitive amine catalysts wherein the catalyst contains at least one imine and at least one tertiary amine moiety. Such catalysts are suitable for the production of polyurethane products.
|
|
WO/2005/063691A1 |
The invention relates to a method for the coammoxidation, i.e. for the simultaneous ammoxidation of ketones, especially of cyclic ketones such as cyclododecanone and cyclohexanone. The ammoxidation method of the invention relates to the ...
|
|
WO/2005/063692A1 |
The invention relates to (hetero)cyclyl carboxanilides of general formula (I), wherein n represents 0, 1, 2, 3, or 4, m represents 1, 2, or 3, Y represents oxygen or sulfur, A represents optionally substituted phenyl or an at least monou...
|
|
WO/2005/061501A2 |
Processes for preparing 10-amino-3-hydroxy-4-oxo-4,6,7,8,9,10-hexahydropyrimido[1,2-
a]azepine-2-carboxylates and related compounds are disclosed. The preparation of carboxamide derivatives from these carboxylates is also disclosed. The ...
|
|
WO/2005/047233A1 |
Compounds of formula (I), wherein Q is a group Q1, Q2, Q3, Q4, Q5, Q6, Q7 or Q8; A is a bridging member A1, A2, A3, A4 or A5 wherein the bridging members A1 to A5 are linked to the group Q at the end carrying the oxygen atom; B either is...
|
|
WO/2005/044782A1 |
A near-infrared absorbing compound that does not contain antimony and arsenic, excelling in stability, especially heat resistance, light stability and resistance to hot moisture; and, produced with the use of the near-infrared absorbing ...
|
|
WO/2005/044899A1 |
A prepolymer, characterized in that it is prepared by the reaction of two compounds A and B which have two or more functional moieties or two or more groups of functional moieties, respectively, and are capable of undergoing a polymeriza...
|
|
WO/2005/044781A1 |
An aromatic polyamine derivative represented by the following formula (1): (1) wherein ring Z represents a monocyclic or polycyclic aromatic ring; Ra, Rb, Rc, and Rd are substituents bonded to the ring Z; and Ra and Rb are the same or di...
|
|
WO/2005/044007A1 |
A pesticide having stabilized high pesticidal effects for crop plants infected with plant diseases, is presented. The pesticide contains a biphenyl derivative represented by the formula (I) or its salt, as an active ingredient: wherein X...
|
|
WO/2005/040096A1 |
A process for the production of asymmetric alkyl compounds which is characterized by comprising the step of mixing a reaction solution containing a glycine imine ester, an alkyl halide, and an asymmetric catalyst having an ability to mak...
|
|
WO/2005/037772A2 |
The invention relates to novel compounds of general formula (I), compositions containing said compounds and to the use thereof for producing pharmaceutical compositions used for human medicine or for veterinary science, and also for cosm...
|
|
WO/2005/037779A2 |
The invention relates to medicinally used substances which specifically inhibit peptidases splitting Gly-Pro-p-nitroanilide. The invention further relates to the use of at least one such substance or at least one pharmaceutical or cosmet...
|
|
WO/2005/037773A1 |
The invention relates to acylhydrazone derivatives of formula (I), which are SGK inhibitors and can be used for the treatment of diseases and afflictions associated with SGK, such as diabetes, obesity, metabolic syndrome (dyslipidaemia),...
|
|
WO/2005/034940A2 |
The invention relates to substances, which specifically inhibit both Ala-p-nitroanilide-cleaving peptidases as well as Gly-Pro-p-nitroanilide-cleaving peptidases, for use in the field of medicine. The invention also relates to the use of...
|
|
WO/2005/033127A1 |
The invention relates to a method for the synthesis of the derivative having formula (I) and to the use thereof for the synthesis of perindopril and the pharmaceutically-acceptable salts thereof.
|
|
WO/2005/030193A1 |
The present invention relates to substituted aryl oximes of formula (I) or a pharmaceutically acceptable salt or ester form thereof wherein R1 is a direct bond to A, C1-C4 alkylene, or -O-C1-C4 alkylene; R2 and R3 are , independently hyd...
|
|
WO/2005/030192A1 |
The present invention relates to substituted indole oximes and methods of using them.
|
|
WO/2005/030191A1 |
The present invention relates to indole oxime derivatives of formula (I) wherein: R1 is -OH, -OC1-C8 alkyl, or NH2; R2 and R3 are, independently, hydrogen, C1-C8 alkyl, -CH2-C3-C6 cycloalkyl, -CH2-pyridinyl, phenyl, or benzyl; R4 is hydr...
|
|
WO/2005/030708A1 |
The inventive method is characterised in that it comprises the following steps consisting in: a) in a reaction medium, reacting (i) an aliphatic ketone having formula R(CO)R', wherein R and R', which may be identical or different, are al...
|
